Eculizumab‐related drug reaction in a patient with neuromyelitis optica. Issue 2 (8th February 2023)
- Record Type:
- Journal Article
- Title:
- Eculizumab‐related drug reaction in a patient with neuromyelitis optica. Issue 2 (8th February 2023)
- Main Title:
- Eculizumab‐related drug reaction in a patient with neuromyelitis optica
- Authors:
- Sharma, Rishi
Romo, Moises
Nelson, Flavia - Abstract:
- Abstract: Eculizumab is approved for treatment of antibody positive neuromyelitis optica, myasthenia gravis, and hematologic disorders like paroxysmal nocturnal hemoglobinuria. Drug rash has not yet been reported as a side effect of eculizumab. We report a case of a cutaneous drug reaction soon after introduction of eculizumab therapy in a patient with refractory neuromyelitis optica. Clinicians should be aware of a drug reaction as a possible adverse reaction to eculizumab. Abstract :
- Is Part Of:
- Clinical case reports. Volume 11:Issue 2(2023)
- Journal:
- Clinical case reports
- Issue:
- Volume 11:Issue 2(2023)
- Issue Display:
- Volume 11, Issue 2 (2023)
- Year:
- 2023
- Volume:
- 11
- Issue:
- 2
- Issue Sort Value:
- 2023-0011-0002-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2023-02-08
- Subjects:
- drug reaction -- eculizumab -- neuroimmunology -- neuromyelitis optica
Medicine -- Periodicals
616.09 - Journal URLs:
- http://onlinelibrary.wiley.com/ ↗
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2050-0904 ↗ - DOI:
- 10.1002/ccr3.6835 ↗
- Languages:
- English
- ISSNs:
- 2050-0904
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 26110.xml